ZL-6201

ZL-6201 · Zai Lab (Shanghai) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZL-6201, covering 2026-03-05 to 2026-03-05. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors [Phase 1]